Reshape Lifesciences Stock (NASDAQ: RSLS) stock price, news, charts, stock research, profile.
You can purchase shares of Reshape Lifesciences (NASDAQ:RSLS) through any online brokerage.
Other companies in Reshape Lifesciences’s space includes: Catheter Precision (AMEX:VTAK), ENDRA Life Sciences (NASDAQ:NDRA), Predictive Oncology (NASDAQ:POAI), Bluejay Diagnostics (NASDAQ:BJDX) and Venus Concept (NASDAQ:VERO).
Reshape Lifesciences has a consensus price target of $4.65.
The stock price for Reshape Lifesciences (NASDAQ: RSLS) is $4.38 last updated December 20, 2024 at 4:00 PM EST.
There are no upcoming dividends for Reshape Lifesciences.
Reshape Lifesciences’s Q3 earnings are confirmed for Thursday, November 14, 2024.
There is no upcoming split for Reshape Lifesciences.
Reshape Lifesciences is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.